Skandinaviska Enskilda Banken (SEB)’s Twist Bioscience TWST Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,692	Closed	-$377K	–	912
2022 Q3	$377K	Sell	10,692 -17,278	-62%	-$734K	﹤0.01%	776
2022 Q2	$978K	Buy	27,970 +17,278	+162%	+$612K	0.01%	708
2022 Q1	$528K	Hold	10,692	–	–	﹤0.01%	828
2021 Q4	$840K	Sell	10,692 -1,637	-13%	-$168K	﹤0.01%	794
2021 Q3	$1.32M	Hold	12,329	–	–	0.01%	740
2021 Q2	$1.64M	Buy	+12,329	New	+$1.43M	0.01%	719
2021 Q1	–	Sell	-100	Closed	-$14K	–	1199
2020 Q4	$14K	Sell	100 -3,700	-97%	-$410K	﹤0.01%	1110
2020 Q3	$289K	Buy	+3,800	New	+$237K	﹤0.01%	884

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s TWST Position: Q4 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Twist Bioscience (TWST) in Q4 2022, closing a stake of 10,692 shares — an estimated $377K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in TWST in Q3 2020 and held it in 8 quarters. The position peaked at $1.64M in Q2 2021. 199 funds tracked by Wall St. Rank hold TWST as of Q4 2022.

Skandinaviska Enskilda Banken (SEB) reported no remaining Twist Bioscience position as of Q4 2022 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 10,692 Twist Bioscience shares in Q4 2022, an estimated $377K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Twist Bioscience in Q3 2020 and held it in 8 quarters.
Skandinaviska Enskilda Banken (SEB)'s Twist Bioscience position peaked at $1.64M in Q2 2021.
199 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2022, filed 8 Feb 2023.